Inclusion complexes of fluorofenidone with β-cyclodextrin and hydroxypropyl-β-cyclodextrin

Drug Development and Industrial Pharmacy

Volumn 35, Issue 7, 2009, Pages 808-813

  Wang, Shengfeng ^a   Ding, Yanfei ^a   Yao, Yao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cyclodextrin; Dissolution rate; Fluorofenidone; Hydroxypropyl cyclodextrin; Inclusion complex; Phase solubility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ANTIFIBROTIC AGENT; BETA CYCLODEXTRIN; FLUOROFENIDONE; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG MIXTURE; DRUG SOLUBILITY; DRUG SYNTHESIS; FREEZE DRYING; PRECIPITATION; SOLID; X RAY DIFFRACTION;

BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; PYRIDONES; SOLUBILITY; X-RAY DIFFRACTION;

EID: 70350637493     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802612944     Document Type: Article

References (19)

1. Cao W, He L, Liu W, Huang Z, Cheng Z. (2006). Determination of AKF-PD in whole blood of rat by HPLC-UV. J Chromatogr B, 833:257-259
2. Tao L, Hu G. (2008). 1-(Substituted phenyl )-5-methyl-2-(1H) pyridone in the manufacture of medicaments for treating fibrosis in organs or tissues, Patent No. EP1878428A, Application No. 06722303.2.
3. Saenger W. Cyclodextrin inclusion compounds in research and laboratory. (1980). Angew Chem Int Ed Engl, 19:344-362
4. Szejtli J. (1998). Introduction and general overview of cyclodextrin chemistry. Chem Rev, 98:1743-1754
5. Uekama K, Hirayama F, Irie T. (1998). Cyclodextrin drug carrier systems. Chem Rev, 98:2045-2076
6. Cortes ME, Sinisterra RD, Avilacampos MJ, Tortamano N, Rocha RG. (2001). The chlorhexidine: β-cyclodextrin inclusion compound: Preparation, characterization and microbiological evaluation. J Incl Phenom Macrocycl Chem, 40:297-302.
7. Brewster ME, Anderson WR, Meinsma D, Moreno D. (1997). Intravenous and oral pharmacokinetic evaluation of a 2.-hydroxypropyl-b-cyclodextrin-based formulation of carbamazepine in the dog: Comparison with commercially available tablets and suspensions. J Pharm Sci, 86:335-339
8. Sarah G, Robert CS. (2005). 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review. Food Chem Toxicol, 43:1451-1459
9. Farcas A, Jarrouxb N, Farcas A-M, Harabagiua V, Gueganb P. (2006). Synthesis and characterization of furosemide complex in β-cyclodextrin. Dig J Nanomater Biostruct, 1:55-60.
10. Higuchi T, Connors KA. (1965). Phase solubility techniques. Adv Anal Chem Instrum, 4:117-212.
11. Ribeiro L, Veiga F. (2002). Complexation of vinpocetine with cyclodextrins in the presence or absence of polymers: Binary and ternary complexes preparation and characterization. J Incl Phenom Macrocycl Chem, 44:251-256
12. Liu L, Zhu S. (2006). Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. J Pharm Biomed Anal, 40:122-127
13. Veiga F, Teixeira-Dias JJC, Kedzierewicz F, Sousa A, Maincent P. (1996). Inclusion complexation of tolbutamide with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin. Int J Pharm, 129:63-71.
14. Marques HC, Hadgraft J, Kllaway I. (1990). Studies of cyclodextrin inclusion complexes I: The salbutamol-cyclodextrin complex as studies by phase solubility and DSC. Int J Pharm, 63:259-266
15. Kohata S, Jyodi K, Ohyoshi A. (1993). Thermal decomposition of cyclodextrins (α-, β-, γ, and modified β-CyD) and of metal-(β-CyD) complexes in the solid phase. Thermochim Acta, 217:187-198
16. Beraldo H, Sinisterra RD, Teixeira LR, Vieira RP, Dorettob MC. (2002). An effective anticonvulsant prepared following a host- guest strategy that uses hydroxypropyl-β-cyclodextrin and benzaldehyde semicarbazone. Biochem Biophys Res Commun, 296:241-246
17. Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P, Van Der Mooter G. (2000). Physicochemical characterization of solid dispersion of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci, 10:311-322
18. Moyano JR, Arias-Blanco MJ, Gines JM, Giordano F. (1997). Solid-state characterization and dissolution characteristics of gliclazide-β- cyclodextrin inclusion complex. Int J Pharm, 148:211-217
19. Veiga F, Fernandes C, Maincent P. (2001). Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary system. Drug Dev Ind Pharm, 27:523-532